Intervention Review

You have free access to this content

Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children

  1. Joshua Z Goldenberg1,
  2. Stephanie SY Ma2,
  3. Jane D Saxton1,
  4. Mark R Martzen3,
  5. Per O Vandvik4,
  6. Kristian Thorlund5,
  7. Gordon H Guyatt5,
  8. Bradley C Johnston6,7,*

Editorial Group: Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group

Published Online: 31 MAY 2013

Assessed as up-to-date: 21 FEB 2013

DOI: 10.1002/14651858.CD006095.pub3


How to Cite

Goldenberg JZ, Ma SSY, Saxton JD, Martzen MR, Vandvik PO, Thorlund K, Guyatt GH, Johnston BC. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD006095. DOI: 10.1002/14651858.CD006095.pub3.

Author Information

  1. 1

    Bastyr University, Seattle, WA, USA

  2. 2

    McMaster University, Division of Plastic & Reconstructive Surgery, Hamilton, Ontario, Canada

  3. 3

    Bastyr University, Bastyr University Research Institute, Kenmore, WA, USA

  4. 4

    Norwegian Knowledge Centre for the Health Services, Oslo, Norway

  5. 5

    McMaster University, Department of Clinical Epidemiology and Biostatistics, Hamilton, Ontario, Canada

  6. 6

    The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada

  7. 7

    University of Toronto, Institute of Health Policy, Management and Evaluation, Toronto, Ontario, Canada

*Bradley C Johnston, bradley.johnston@sickkids.ca. bjohnst@mcmaster.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 31 MAY 2013

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kari A. Mergenhagen, Amy L. Wojciechowski, Joseph A. Paladino, A Review of the Economics of Treating Clostridium difficile Infection, PharmacoEconomics, 2014, 32, 7, 639

    CrossRef

  2. 2
    Lindsay M. Urben, Jennifer Wiedmar, Erica Boettcher, Rodrigo Cavallazzi, Robert G. Martindale, Stephen A. McClave, Bugs or Drugs: Are Probiotics Safe for Use in the Critically Ill?, Current Gastroenterology Reports, 2014, 16, 7

    CrossRef

  3. 3
    Jonathan M. Keller, Christina M. Surawicz, Clostridium difficile Infection in the Elderly, Clinics in Geriatric Medicine, 2014, 30, 1, 79

    CrossRef

  4. 4
    Sabina Fijan, Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature, International Journal of Environmental Research and Public Health, 2014, 11, 5, 4745

    CrossRef

  5. 5
    Saskia van Hemert, Anne C. Breedveld, Jörgen M. P. Rovers, Jan P. W. Vermeiden, Ben J. M. Witteman, Marcel G. Smits, Nicole M. de Roos, Migraine Associated with Gastrointestinal Disorders: Review of the Literature and Clinical Implications, Frontiers in Neurology, 2014, 5,

    CrossRef

  6. 6
    Szimonetta Lohner, Daniela Küllenberg, Gerd Antes, Tamás Decsi, Joerg J Meerpohl, Prebiotics in healthy infants and children for prevention of acute infectious diseases: a systematic review and meta-analysis, Nutrition Reviews, 2014, 72, 8
  7. 7
    Gian Zuccotti, Fabio Meneghin, The role of probiotics in nosocomial infections, Italian Journal of Pediatrics, 2014, 40, Suppl 2, A16

    CrossRef

  8. 8
    L.N. Smug, S. Salminen, M.E. Sanders, S. Ebner, Yoghurt and probiotic bacteria in dietary guidelines of the member states of the European Union, Beneficial Microbes, 2014, 5, 1, 61

    CrossRef

  9. 9
    Robert G. Martindale, Clifford W. Deveney, Preoperative Risk Reduction, Surgical Clinics of North America, 2013, 93, 5, 1041

    CrossRef

  10. 10
    Fleur T. van de Wetering, Pauline Heus, Leen Verleye, Geertjan van Tienhoven, Rob JPM Scholten, Probiotics for the prevention or treatment of chemotherapy or radiotherapy related diarrhoea in cancer patients, The Cochrane Library,